5α-Reductase: History And Clinical Importance

    January 2004 in “ PubMed Central ”
    Leonard S. Marks
    Studysummary This article reviews the use of 5α-reductase inhibitors for treating benign prostatic hyperplasia, suggesting potential benefits beyond symptom relief, but it reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Related research 5

    1. Why Would Men Use Finasteride in 2005? Current Prostate Reports · 2005
    2. 5alpha-Reductase: History and Clinical Importance PubMed · 2004
    3. Long-Term Experience With 5-Alpha-Reductase Inhibitors PubMed · 2003
    4. Current Treatment of Benign Prostatic Hyperplasia Biomedicine & pharmacotherapy · 1995
    5. Finasteride Drugs · 1993